Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy

The New England Journal of Medicine
T S HermanT E Moon

Abstract

Two double-blind, crossover trials comparing the antiemetic effectiveness of nabilone, a new synthetic cannabinoid, with that of prochlorperazine were conducted in patients with severe nausea and vomiting associated with anticancer chemotherapy. Of 113 patients evaluated, 90 (80 per cent) responded to nabilone therapy, whereas only 36 (32 per cent) responded to prochlorperazine (P less than 0.001). Complete relief of symptoms was infrequent, occurring only in nine patients (8 per cent) given nabilone. When both drugs were compared, both nausea (P less than 0.01) and vomiting episodes (P less than 0.001) were significantly lower in patients given nabilone. Moreover, patients clearly favored nabilone for continued use (P less than 0.001). Predominant side effects noted by patients were similar for both agents and included somnolence, dry mouth and dizziness but were about twice as frequent and more often severe in patients receiving nabilone. In addition, four patients (3 per cent) taking nabilone had side effects (hallucinations in three, hypotension in one) that required medical attention. Euphoria associated with nabilone was infrequent (16 per cent) and mild.

References

Jul 1, 1977·Clinical Pharmacology and Therapeutics·A RubinB D Obermeyer
Oct 16, 1975·The New England Journal of Medicine·S E SallanE Frei
May 1, 1975·Toxicology and Applied Pharmacology·H RosendrantzC Braude
Dec 1, 1975·Clinical Pharmacology and Therapeutics·L Lemberger, H Rowe
Dec 13, 1968·Science·A T WeilJ M Nelsen
Oct 13, 1969·JAMA : the Journal of the American Medical Association·J A Talbott, J W Teague
Apr 30, 1970·The New England Journal of Medicine·A T Weil
Dec 1, 1970·Annals of Internal Medicine·V T DevitaP P Carbone
Oct 12, 1963·JAMA : the Journal of the American Medical Association·C G MOERTELR P GAGE

❮ Previous
Next ❯

Citations

Jan 1, 1980·Psychopharmacology·R M GlassM W Fischman
Sep 1, 1989·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·R CrambG Hirano
Oct 14, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lawrence H EinhornMatti Aapro
May 28, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lawrence H EinhornPetra Feyer
Jan 1, 1984·Molecular Aspects of Medicine·J H Barnes
Sep 21, 1991·Lancet
Aug 5, 2003·Pharmacology, Biochemistry, and Behavior·Giovanni DianaMassimo Pieri
Sep 12, 1981·Lancet·J T DuQuesne
Feb 11, 2000·Drug and Alcohol Dependence·L E Hollister
Aug 20, 1981·The New England Journal of Medicine·R Ader, L J Grota
Jan 5, 1984·The New England Journal of Medicine·T A LouisM Polansky
Aug 22, 2008·Journal of Palliative Medicine·Vincent Maida
May 1, 1986·Archives of Disease in Childhood·A M DalzellJ S Lilleyman
Nov 24, 1979·British Medical Journal
Apr 24, 1982·British Medical Journal·D N Bateman, M D Rawlins
Jan 29, 1983·British Medical Journal·J R Trounce
Mar 5, 1983·British Medical Journal·T SenskyK W Pettingale
Nov 5, 2013·European Journal of Pharmacology·Keith A SharkeyLinda A Parker
May 6, 2014·Experimental Brain Research·Erin M RockLinda A Parker
Jul 15, 1983·Klinische Wochenschrift·H H GerhartzE Hiller
Jan 17, 2016·Analytical Biochemistry·Chaela S PresleyBob M Moore
Jan 1, 1984·Cancer Investigation·J J Fiore, R J Gralla
Apr 1, 1987·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·H R SullivanP G Wood
Feb 3, 2016·Journal of Natural Products·Oier Aizpurua-OlaizolaAresatz Usobiaga
Feb 4, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Nabil AdraLawrence H Einhorn
Oct 31, 2015·Annual Review of Medicine·Samuel T WilkinsonDeepak Cyril D'Souza
Mar 1, 1985·International Journal of Radiation Oncology, Biology, Physics·M B ParliamentT Clayton
Dec 17, 2014·CA: a Cancer Journal for Clinicians·Joan L Kramer
Sep 1, 1984·Cancer Treatment Reviews·M T Bakowski
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A NobleS G Dilly
Aug 1, 1981·Journal of Clinical Pharmacology·J LaszloS E Sallan
Aug 1, 1981·Journal of Clinical Pharmacology·R M GlassM W Fischman
Aug 1, 1981·Journal of Clinical Pharmacology·C M CroninJ Laszlo
Jun 1, 1985·Journal of Clinical and Hospital Pharmacy·L J Dodds
Apr 1, 1983·Journal of Clinical Pharmacology·H GongB Calvarese
Aug 1, 1981·Journal of Clinical Pharmacology·J S PentaJ S Macdonald
Aug 1, 1981·Journal of Clinical Pharmacology·R B DiasioB E Satterwhite
Aug 1, 1981·Journal of Clinical Pharmacology·L E McCarthy, H L Borison

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.